1Eanders E, Erlandsen E J, Pedersen OL,et al .Serum cystatin C as an endogenous para- meter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol, 2000, 54 (3):203-209.
4Mussap M,Dalla VM, Fioretto P,et al.Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients[J]. Kidney Int,2002,61(4): 1453-1461.
5Peralta CA,Katz R,Sarnak MJ,et al.Cystatin C identifies chronic kidney disease patients at higher risk for complications[J].J Am Soc Nephrol, 2011,22(1).. 147-155.
2Roos J F, Doust J, Tett S E, et al. Diagnostic accuracy of cystatin c compared to serum creatinine for the estimetion of renal dysfunction in adults and children meta-analysis [J]. Clin Biochem, 2007,4 ( 5 ) : 383-391.
3Filler G, Bokenkamp A, Hofmann W, et al. CystatinC as amarker of GFR- history, indications, and future research. Clin Bio-chem, 2005, 38 ( 1 ) : 1-8.
4Dickinson DP. Salivary( SD2 type) cystatins : over one billion years in themarking but towhatpurpose?. CritRevOralBiolMed, 2002, 13 (6) : 485-508.
5Stabue B, Vrhovec L, Stabuc-Silih M, ct al. Improved prediction of decreased creatinine clearance by serum cystatin C : use in cancer patients before and during chemotherapy. Clin Chem, 2000, 46 (2) : 193-197.
6Jacobsson B, Lignelid H, Bergerheim US. Transthyretin and cystatinC are catabolized in proximal tubular epithelial ceils and the proteins are notuseful asmarkers for renal cell carcinomas. Histnpathol- ogy, 1995, 26(6) : 559-564.
